Compositions and methods for the treatment of hemoglobinopathies
US11466271B2 · kind B2 · utility
0Cited by
62References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 5, 2018 |
| Grant date | Oct 11, 2022 |
| Priority date | — |
| Expiry date | May 5, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to genome editing systems, reagents and methods for the treatment of hemoglobinopathies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.